Anavex Life Sciences Corp (AVXL)

[Investor2014]

The physiological and behavioral consequences of these changes are still largely unknown; however, with the exception of stimulant addiction and cancer, activation of s1R are typically associated with both physiological and behavioral positive outcomes.

I expect someone will pick up on these potential and unfortunate side effects of S1r agonists such as A2-73 and get any further research let alone regulatory approvals banned forthwith.

No matter how many CNS patients might benefit, we just cannot allow even one AD patient get addictions or die from cancer because of such nasty side effects.